What it sells
Diagnostics-as-a-service.
Business model breakdown
Buyer: who owns the budget?
UnverifiedProduct/partnership leads at digital health, longevity, telemedicine and pharma companies, and payers/insurers.
Trigger: what makes them buy now?
Wanting to offer lab-grade diagnostics without building lab, logistics and compliance infrastructure; "Live in 4 weeks".
Workflow: what inputs become what output?
Configure test flow, ship kits, collect samples, lab analysis, medical validation, results into partner platform; claims live in 4 weeks.
Economics: what it saves and how it charges
UnverifiedDiagnostics-as-a-service: white-label orchestration platform plus partner labs and logistics; per-test pricing not shown.
Distribution: how it reaches customers
Discovery-call-led sales.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-03-17 | — | €3M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.